Our work gets us noticed. UBMD physicians make headlines for raising the bar on clinical care, leading community health initatives and conducting groundbreaking research, among other advancements and accomplishments.
The nation’s oldest charitable organization dedicated to improving the lives of older Americans has chosen UB as its partner in an effort to better protect older adults from preventable medical errors.
Steven E. Lipshultz, MD, the A. Conger Goodyear Professor and Chair of pediatrics, is co-author on a new paper that validates the long-term efficacy and safety of metabolic and bariatric surgery (MBS) for treatment of adolescent obesity.
The Department of Psychiatry’s 17th Annual Comprehensive Review of Psychiatry conference featured an array of internationally renowned speakers updating the latest advances in the diagnosis and management of a wide array of psychiatric disorders.
The University at Buffalo and UBMD Physicians’ Group have launched the region’s only long COVID registry in order to learn more about the condition and to connect Western New Yorkers with treatment options and the potential to participate in clinical trials.
UB and UBMD Physicians’ Group have launched the long COVID registry in order to learn more about the condition and to connect Western New Yorkers with treatment options and the potential to participate in clinical trials.
The University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UB CAT) has awarded six life sciences companies a total of $253,000 to support new biomedical technologies.
Nineteen faculty members with clinical and research experience have joined the departments of Biomedical Informatics, Family Medicine, Medicine, Orthopaedics, Pathology and Anatomical Sciences, Pediatrics, Physiology and Biophysics, and Psychiatry.
The Jacobs School of Medicine and Biomedical Sciences team that a decade ago helped usher in a new era in acute stroke treatment has turned its innovative approach to addressing the rare but potentially deadly phenomena when multiple blood clots strike deep in the veins of the brain.
The UB team that a decade ago helped usher in a new era in acute stroke treatment has turned its innovative approach to addressing the rare but potentially deadly phenomena when multiple blood clots strike deep in the veins of the brain.
